LivaNova PLC - Ordinary Shares (LIVN)
LIVN moved a median of +0.04% 30 minutes after news, and +0.45% by the close. How LIVN actually reacts to news — the realized, point-in-time move the market made, measured across 275 labeled events over the last three years with zero look-ahead.
LIVN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.01% | 55% | 274 |
| 30-min | +0.04% | 51% | 275 |
| 60-min | +0.37% | 56% | 275 |
| to close | +0.45% | 55% | 275 |
| Middle 50% of LIVN reactions | -0.41% to +0.94% |
|---|---|
| Median reaction (30-min) | +0.04% |
| Measured reactions | 275 |
Half of all LivaNova PLC - Ordinary Shares news events land between -0.41% and +0.94% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How LIVN reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 21 | +0.22% | 62% | +0.19% |
| Analyst downgrades | 11 | -0.01% | 46% | +0.86% |
| Rating reiterations | 70 | +0.01% | 50% | +0.13% |
| Price-target raises | 19 | -0.21% | 32% | +0.46% |
| Price-target cuts | 10 | +0.89% | 80% | -0.33% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how LIVN ranks against every other measured name →
That’s how LIVN usually reacts — get an email when it moves on news →Email me when LIVN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to LIVN's baseline. Nothing else.
Recent LIVN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| LivaNova to Announce Third-Quarter 2026 Results | Press release | Business Wire | +0.00% | -1.57% | |
| LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September | Press release | Business Wire | +0.01% | -2.75% | |
| Form 10-Q LivaNova PLC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.40% | +2.27% | |
| Form 8-K LivaNova PLC For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +0.16% | -2.17% | |
| Form IRANNOTICE LivaNova PLC | SEC filing · Form IRANNOTICE | SEC EDGAR | +0.26% | +2.21% | |
| LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance | Press release | Business Wire | +0.16% | -2.17% | |
| LivaNova to Announce Second-Quarter 2026 Results | Press release | Business Wire | +1.18% | +1.61% | |
| LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea | Press release | Business Wire | -0.19% | -1.25% | |
| Form 8-K LivaNova PLC For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | -0.55% | +1.83% | |
| Jette Nygaard-Andersen Joins LivaNova Board as a New Director | Press release | Business Wire | -0.01% | -0.49% | |
| LivaNova Appoints Anne Liddy as Chief Legal Officer | Press release | Business Wire | +0.38% | -1.74% | |
| Form SD LivaNova PLC | SEC filing · Form SD | SEC EDGAR | +0.30% | +0.83% | |
| LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit | Press release | Business Wire | -1.29% | +0.66% | |
| LivaNova to Present at Goldman Sachs Global Healthcare Conference in June | Press release | Business Wire | -0.86% | +0.95% | |
| Form 10-Q LivaNova PLC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.07% | +0.90% | |
| Form 8-K LivaNova PLC For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +6.48% | +8.62% | |
| Form IRANNOTICE LivaNova PLC | SEC filing · Form IRANNOTICE | SEC EDGAR | -0.07% | +0.89% | |
| LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance | Press release | Business Wire | +6.48% | +8.62% | |
| Form ARS LivaNova PLC For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.80% | -2.84% | |
| Form DEF 14A LivaNova PLC For: Jun 10 | SEC filing · Form DEF | SEC EDGAR | -0.80% | -2.84% | |
| Form DEFA14A LivaNova PLC | SEC filing · Form DEFA14A | SEC EDGAR | -0.80% | -2.84% | |
| Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea | Press release | Business Wire | +0.20% | -2.06% | |
| LivaNova to Announce First-Quarter 2026 Results | Press release | Business Wire | -0.15% | +0.10% | |
| LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea | Press release | Business Wire | -0.76% | +0.02% | |
| Form 10-K LivaNova PLC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.14% | +0.77% | |
| Form 8-K LivaNova PLC For: Feb 25 | SEC filing · Form 8-K | SEC EDGAR | +1.48% | +8.51% | |
| Form IRANNOTICE LivaNova PLC | SEC filing · Form IRANNOTICE | SEC EDGAR | +0.02% | +0.95% | |
| LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance | Press release | Business Wire | +1.48% | +8.51% | |
| LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results | Press release | Business Wire | +0.65% | +2.53% | |
| Form 8-K LivaNova PLC For: Jan 12 | SEC filing · Form 8-K | SEC EDGAR | +0.07% | -0.41% | |
| LivaNova to Present at J.P. Morgan Healthcare Conference in January | Press release | Business Wire | +0.17% | +0.57% | |
| Cadence Neuroscience Announces Medical Device Veteran Daniel Moore as Independent Board Director | Press release | PR Web | +0.65% | +1.01% | |
| LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting | Press release | Business Wire | +0.09% | -0.53% | |
| LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea | Press release | Business Wire | -0.10% | +0.78% | |
| LivaNova to Present at Piper Sandler Healthcare Conference in December | Press release | Business Wire | +0.73% | +4.59% | |
| LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services | Press release | Business Wire | -0.48% | +2.48% | |
| LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day | Press release | Business Wire | +0.16% | -1.12% | |
| Form 10-Q LivaNova PLC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.13% | -2.47% | |
| Form 8-K LivaNova PLC For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | +2.13% | -2.36% | |
| Form IRANNOTICE LivaNova PLC | SEC filing · Form IRANNOTICE | SEC EDGAR | +0.26% | -2.16% | |
| LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance | Press release | Business Wire | +2.13% | -2.36% | |
| LivaNova to Present at Wolfe Research Healthcare Conference in November | Press release | Business Wire | +0.49% | -0.51% | |
| LivaNova to Announce Third-Quarter 2025 Results | Press release | Business Wire | -0.30% | +1.50% | |
| LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting | Press release | Business Wire | -0.33% | -1.58% | |
| Form 8-K LivaNova PLC For: Sep 03 | SEC filing · Form 8-K | SEC EDGAR | -0.70% | +3.10% | |
| LivaNova Appoints Donald Zurbay as a New Director | Press release | Business Wire | -0.70% | +3.10% | |
| LivaNova to Host Investor Day on November 12, 2025 | Press release | Business Wire | -0.05% | +0.63% | |
| LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September | Press release | Business Wire | +0.17% | +4.56% | |
| LivaNova Launches Essenz Perfusion System in China | Press release | Business Wire | -0.40% | -0.67% | |
| Form 10-Q LivaNova PLC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.11% | +2.73% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the LIVN section they belong to.
Where else LIVN is measured.
LIVN earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | 275 | -0.27% | 42% |
| Evolus, Inc. (EOLS) | 275 | +0.08% | 51% |
| Puma Biotechnology Inc (PBYI) | 274 | +0.44% | 55% |
| PRANA BIOTECH (PRAN) | 274 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is LivaNova PLC - Ordinary Shares's median reaction calculated?
Every labeled LIVN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 275 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of LIVN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does LIVN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.